iShares NASDAQ US Biotechnology UCITS ETF (LON:BTEE)

London flag London · Delayed Price · Currency is GBP · Price in USD
6.86
-0.05 (-0.76%)
Sep 4, 2025, 4:13 PM BST
-0.76%
Assets20.95M
Expense Ratio0.35%
PE Ratio17.67
Dividend (ttm)0.02
Dividend Yield0.46%
Ex-Dividend DateJun 12, 2025
Payout FrequencySemi-Annual
Payout Ratio6.00%
1-Year Return-1.66%
Volume36,549
Open6.93
Previous Close6.92
Day's Range6.86 - 6.97
52-Week Low5.22
52-Week High7.20
Beta0.77
Holdings263
Inception DateMar 6, 2018

About BTEE

iShares NASDAQ US Biotechnology UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the biotechnology and pharmaceuticals sector. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the NASDAQ Biotechnology Index, by employing representative sampling methodology. iShares NASDAQ US Biotechnology UCITS ETF was formed on October 19, 2017 and is domiciled in Ireland.

Asset Class Equity
Category Health Care
Stock Exchange London Stock Exchange
Ticker Symbol BTEE
Provider iShares
Index Tracked NASDAQ Biotechnology Index

Performance

BTEE had a total return of -1.66% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.45%.

Top 10 Holdings

45.17% of assets
NameSymbolWeight
Gilead Sciences, Inc.GILD7.21%
Amgen Inc.AMGN7.02%
Vertex Pharmaceuticals IncorporatedVRTX6.22%
Regeneron Pharmaceuticals, Inc.REGN6.21%
Alnylam Pharmaceuticals, Inc.ALNY5.15%
AstraZeneca PLCAZN4.79%
Insmed IncorporatedINSM2.52%
argenx SEARGX2.29%
Biogen Inc.BIIB1.97%
Summit Therapeutics Inc.SMMT1.79%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Jun 12, 2025£0.01472Jun 25, 2025
Dec 12, 2024£0.0089Dec 27, 2024
Jun 13, 2024£0.01372Jun 26, 2024
Dec 14, 2023£0.00846Dec 29, 2023
Jun 15, 2023£0.01113Jun 28, 2023
Dec 15, 2022£0.00851Dec 30, 2022
Full Dividend History